News

Press Releases

September 17, 2020 – Proniras Corporation Announces National Institute on Drug Abuse (NIDA) Grant Award to Pursue Treatment for Opioid Withdrawal

April 27, 2018 – Accelerator Life Science Partners Launches Proniras Corporation to Support Development of Tezampanel in the Treatment of Seizure Disorders

April 27, 2018 – Proniras Corporation Awarded Contract Worth Up to $89.5 Million from U.S. Biomedical Advanced Research and Development Authority to Develop Tezampanel as a Medical Countermeasure for Nerve Agent-Induced Seizures

In the News

April 27, 2018 – Proniras Corp. launches in Seattle, scores $89.5 million contract to develop new seizure drug (Geekwire.com)